41.000 makale bulundu

The MICAL family at the Rho-Rab interface: coordinating actin dynamics through oxidation and scaffolding.

Micovic K, Olson MF.

Biochem J · 2026-10-01

DOI: 10.1042/bcj20250118PMID: 42806710

Bioinspired Nanomaterials for Parkinson's Disease: Engineering Membrane Interfaces to Overcome the Blood-Brain Barrier and Enable Neuron-Targeted Delivery.

Huang Q, Zuo Y, Xie Y, Liu Z, Wang L, Xu H, Yu M, Liu C.

ACS Biomater Sci Eng · 2026-10-01

DOI: 10.1021/acsbiomaterials.6c01137PMID: 42814893

From bench to beside: luteolin's therapeutic promise in neurological disorders.

Zhu W, Yuan N, Tang M, She K, Chen M, Huang M, Feng R, Ma Q, Chen J.

Chin J Nat Med · 2026-10-01

DOI: 10.1016/s1875-5364(26)61211-3PMID: 42816030

Proteostaz (in) eylem: nörodejeneratif hastalıkta ko-patolojilerin rolü.

Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease.

Morley JF.

Philos Trans R Soc Lond B Biol Sci · 2026-10-01

DOI: 10.1098/rstb.2025.0273PMID: 42817633

Alfa-sinüklein proteostazının hücresel ve sistemik değiştiricileri.

Cellular and systemic modifiers of alpha-synuclein proteostasis.

Couzijn S, Ainslie AP, Herron-Bedoya A, Nollen EAA.

Philos Trans R Soc Lond B Biol Sci · 2026-10-01

DOI: 10.1098/rstb.2025.0275PMID: 42817634

Mikrobiyota-proteostaz ekseni: nörodejeneratif hastalıklarda etkiler.

The microbiota-proteostasis axis: implications in neurodegenerative diseases.

Czyż DM, Brown BM.

Philos Trans R Soc Lond B Biol Sci · 2026-10-01

DOI: 10.1098/rstb.2025.0265PMID: 42817639

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation-Related Diseases.

Lin Y, Cho I, Zhu X, Wang K, Zhu L, Wong W, Murray M, Zhou F.

Phytother Res · 2026-10-01

DOI: 10.1002/ptr.70467PMID: 42820327

App Store metadata ve kullanıcı incelemelerinde değer: Parkinson ve demans uygulamalarının kalitesine ikili bir bakış açısı.

Value in app store metadata and user reviews: A dual perspective on quality of Parkinson's and dementia apps.

Schwaninger I, Ighanian P, Borga L, Giraitis M, Hoogendoorn P, Klucken J.

PLOS Digit Health · 2026-10-01

DOI: 10.1371/journal.pdig.0001730PMID: 42821639

The good, the bad, and the ugly: A three-circuit model of Parkinson's tremor.

Helmich RC, van den Berg KRE.

Rev Neurol (Paris) · 2026-10-01

DOI: 10.1016/j.neurol.2026.09.003PMID: 42823256

From Design to Bedside: Brain-Targeted Engineered Nanoparticles and Predictive Modeling for Neurodegenerative Diseases Therapeutics.

Nguyen N, Yuan M, Wang Y.

Pharm Res · 2026-10-01

DOI: 10.1007/s11095-026-04201-5PMID: 42823573

Nörodejeneratif Hastalıklarda Platelet Faktörünün Rolüne İlişkin İçgörüler.

Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases.

Tian Q, Tong Y, Yu F, Hu X.

CNS Neurosci Ther · 2026-10-01

DOI: 10.1002/cns.71118PMID: 42837273

Sağlık ve Hastalıkta Synaptic Proteostasis.

Synaptic Proteostasis in Health and Disease.

Donlin-Asp PG, Clayton EL.

J Neurochem · 2026-10-01

DOI: 10.1111/jnc.70565PMID: 42847522